The Magazine of Corporate Responsibility

Tag Archive for ‘Johnson & Johnson’

Drug Companies Pay Up in Illegal Marketing Cases, But Are Penalties Enough?

Big Pharma has written more than $30 billion in checks in the last 10 years to resolve government allegations of illegal marketing, according to consumer watchdog group Public Citizen. Yet those sums are essentially petty cash for the drug giants, says Public Citizen, amounting to less than 5 percent of the net profits raked in by the 11 largest global pharmaceuticals firms over a similar period.

Pain Foundation Shuts Down As Senators Investigate Prescription Narcotics

As the U.S. Senate Finance Committee launched an investigation into makers of narcotic painkillers and groups that champion them, a leading pain advocacy organization said it was dissolving “due to irreparable economic circumstances.” The group received 90 percent of its $5 million in funding in 2010 from the drug and medical-device industry.

UN Council Endorses Principles on Business and Human Rights

The UN’s endorsement of the Guiding Principles on Business and Human Rights marks not just a successful end to the mandate of UN Special Representative John Ruggie. It also signals a new beginning for business and human rights as companies around the world begin to implement the principles to ensure respect for human rights in all their operations.

Docs on Pharma Payroll Have Blemished Records

Drug companies say they hire the most-respected doctors in their fields for the critical task of teaching about the benefits and risks of their drugs. But an investigation by ProPublica uncovered hundreds of doctors on company payrolls who had been accused of professional misconduct, were disciplined by state boards or lacked credentials as researchers or specialists.

Johnson & Johnson, Under Investigation, Tops CSR Index

Johnson & Johnson topped a list of companies perceived by American consumers as having the best reputations for corporate social responsibility practices. Months after research for the Index was conducted, the company admitted that it misled regulators and consumers by using contractors to buy defective Motrin painkiller products from store shelves rather than announce a recall.

Opinion: BP puts costs ahead of environment. Are we surprised?

BP’s failure to stop the worst oil spill in U.S. history is indicative of a much larger problem with companies that have embraced one of the central ideas in management today: stakeholder theory. The idea that companies can meet the needs of “stakeholders” leaves them open to moral abuse without normative principles at its core.

Conscious Capitalism: New Models for 21st Century Business

Columnist Gael O’Brien takes a look at a new organization and a group of business leaders who believe that a company can be profitable while also safeguarding trust, reputation, and credibility with stakeholders. One CEO poses the question: “Is it possible to create an enterprise where everybody wins?”

Toyota Recall: Five Critical Lessons

Fixing the problem and ensuring that something like it doesn’t happen again will require an all-out effort by Toyota, from assembly line to the boardroom. Even then, there are no guarantees. Maintaining a good corporate reputation in the 21st century is tricky business indeed.